Citations (191)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Anmar Al-Taie & Ece Özcan Bülbül. (2024) A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches. Journal of Drug Targeting 32:1, pages 45-56.
Read now
Read now
Divya Kandari & Rakesh Bhatnagar. (2023) Antibody engineering and its therapeutic applications. International Reviews of Immunology 42:2, pages 156-183.
Read now
Read now
Monica L. Fernández-Quintero, Katharina B. Kroell, Lukas J. Grunewald, Anna-Lena M. Fischer, Jakob R. Riccabona & Klaus R. Liedl. (2022) CDR loop interactions can determine heavy and light chain pairing preferences in bispecific antibodies. mAbs 14:1.
Read now
Read now
Celine A.N. Sewnath, Leonie M. Behrens & Marjolein van Egmond. (2022) Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer. Expert Opinion on Biological Therapy 22:8, pages 983-995.
Read now
Read now
Eva Germovsek, Ming Cheng & Craig Giragossian. (2021) Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings. mAbs 13:1.
Read now
Read now
Sivan Cohen, Shan Chung, Christoph Spiess, Victor Lundin, Eric Stefanich, Steven T. Laing, Vanessa Clark, Jochen Brumm, Ying Zhou, Catherine Huang, Joyce Guerrero, Srividya Myneni, Rajbharan Yadav, Ketevan Siradze & Kun Peng. (2021) An integrated approach for characterizing immunogenic responses toward a bispecific antibody. mAbs 13:1.
Read now
Read now
Ruth Alonso-Alonso, Marta Rodriguez, Daniel Morillo, Raul Cordoba & Miguel A Piris. (2020) An analysis of genetic targets for guiding clinical management of follicular lymphoma. Expert Review of Hematology 13:12, pages 1361-1372.
Read now
Read now
Christoph Gstöttner, Dietmar Reusch, Markus Haberger, Irina Dragan, Peter Van Veelen, David P. A. Kilgour, Yury O. Tsybin, Yuri E. M. van der Burgt, Manfred Wuhrer & Simone Nicolardi. (2020) Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometry. mAbs 12:1.
Read now
Read now
Deepak Mittal, Dipti Vijayan, Joost Neijssen, Joost Kreijtz, Maurice M. J. M. Habraken, Hans Van Eenennaam, Andrea Van Elsas & Mark J. Smyth. (2019) Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy. OncoImmunology 8:11.
Read now
Read now
Adam R. Evans, Michael T. Capaldi, Geetha Goparaju, David Colter, Frank F. Shi, Sarah Aubert, Lian-Chao Li, Jingjie Mo, Michael J. Lewis, Ping Hu, Pedro Alfonso & Promod Mehndiratta. (2019) Using bispecific antibodies in forced degradation studies to analyze the structure–function relationships of symmetrically and asymmetrically modified antibodies. mAbs 11:6, pages 1101-1112.
Read now
Read now
Kristina Ellwanger, Uwe Reusch, Ivica Fucek, Susanne Wingert, Thorsten Ross, Thomas Müller, Ute Schniegler-Mattox, Torsten Haneke, Erich Rajkovic, Joachim Koch, Martin Treder & Michael Tesar. (2019) Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity. mAbs 11:5, pages 899-918.
Read now
Read now
Oliver Seifert, Alexander Rau, Nadine Beha, Fabian Richter & Roland E. Kontermann. (2019) Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules. mAbs 11:5, pages 919-929.
Read now
Read now
Chen Chen, Tetsuya Wakabayashi, Masaru Muraoka, Feng Shu, Chia Wei Shan, Chong Chor Kun, Ching Tim Jang, Ishin Soehano, Yuichiro Shimizu, Tomoyuki Igawa & Jun-Ichi Nezu. (2019) Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency. mAbs 11:4, pages 632-638.
Read now
Read now
Articles from other publishers (178)
Ya Wang, Jie Chen, Sen Zhang, Hang Jiang, Jianqing Zhu, Guangyi Jiang, Yichang Liu, Yingdi Zhu & Juan Li. (2024) Bispecific Nanobody‐Aptamer Conjugates for Enhanced Cancer Therapy in Solid Tumors. Small.
Crossref
Crossref
Anmar Al-Taie & Najat Sheta. (2024) Clinically Approved Monoclonal Antibodies–based Immunotherapy: Association With Glycemic Control and Impact Role of Clinical Pharmacist for Cancer Patient Care. Clinical Therapeutics 46:1, pages e29-e44.
Crossref
Crossref
Ze Tian, Chunhua Shi, Guojun Yang, Jason K. Allen, Qing Shi, Amin AL-Shami, Jill Wardell Olson, Melinda G. Smith, Qing Chang, Jasbir Kaur, Junping You, Timothy E. Lofton, Michelle A. Gonzalez, Qi Zhang, DongXing Zha, Sarah K. Tasian, Nitin Jain, Marina Y. Konopleva, Timothy Heffernan & Jeffrey J. Molldrem. (2023) Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL. Leukemia 37:10, pages 2006-2016.
Crossref
Crossref
Wu Lin, Yingzi Zhang, Yan Yang, Ben Lin, Mengjia Zhu, Jinling Xu, YiRan Chen, Weiwei Wu, Bingliang Chen, Xiangliu Chen, Jin Liu, Haohao Wang, Fei Teng, Xiongfei Yu, Haiyong Wang, Jun Lu, Quan Zhou & Lisong Teng. (2023) Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis. Advanced Science 10:30.
Crossref
Crossref
Yong Hwan Choi, Ha Seung Song, Su Keun Lee, Chi Hun Song, Ji Hoe Kim & Kyung Ho Han. (2023) Advancements in Bispecific Antibody Development and Research Trends. Microbiology and Biotechnology Letters 51:3, pages 223-242.
Crossref
Crossref
Minchuan Zhang, Kong-Peng Lam & Shengli Xu. (2023) Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Noam Tzuri, Ksenia M. Yegodayev, Ofra Novoplansky, Moshe Elkabets, Amir Aharoni & Niv Papo. (2023) Developing a dual VEGF/PDL1 inhibitor based on high-affinity scFv heterodimers as an anti-cancer therapeutic strategy. Scientific Reports 13:1.
Crossref
Crossref
Tanja Ziegengeist, Jennifer Orth, Katja Kroll, Marion Schneider, Nadja Spindler, Dilyana Dimova, Severin Handschuh, Arnd Brandenburg, Reto Ossola, Norbert Furtmann, Joerg Birkenfeld, Christian Beil, Dietmar Hoffmann, Thorsten Schmidt, Rebecca Sendak, Melanie Fischer, Soraya Hölper & Jennifer Kühn. (2023) High-Throughput and Format-Agnostic Mispairing Assay for Multispecific Antibodies Using Intact Mass Spectrometry. Analytical Chemistry 95:27, pages 10265-10278.
Crossref
Crossref
Linghui Qian, Xuefen Lin, Xue Gao, Rizwan Ullah Khan, Jia-Yu Liao, Shubo Du, Jingyan Ge, Su Zeng & Shao Q. Yao. (2023) The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics. Chemical Reviews 123:12, pages 7782-7853.
Crossref
Crossref
Ryo Okuyama. (2023) Chronological Analysis of First-in-Class Drugs Approved from 2011 to 2022: Their Technological Trend and Origin. Pharmaceutics 15:7, pages 1794.
Crossref
Crossref
Ryo Okuyama. (2023) Modality diversification and best-in-class small-molecule drugs: Recent trend of orphan drug development. Medicine in Drug Discovery 18, pages 100156.
Crossref
Crossref
Minna Xiao, Qinglai Tang, Shiying Zeng, Qian Yang, Xinming Yang, Xinying Tong, Gangcai Zhu, Lanjie Lei & Shisheng Li. (2023) Emerging biomaterials for tumor immunotherapy. Biomaterials Research 27:1.
Crossref
Crossref
V. V. Smirnov, O. A. Petukhova, A. V. Filatov, D. A. Kudlay & M. R. Khaitov. (2023) Studying the pharmacokinetics of biotechnological medicinal products on the example of monoclonal antibodies. Biological Products. Prevention, Diagnosis, Treatment 23:2, pages 173-180.
Crossref
Crossref
Vivek Reddy Murthannagari, Ganesh Gonna Nandhi Krishnan, Kavitha Viswabramhana Manu, Chandu Thoti Jayachandraiah, Praharsh Kumar Mandadhi Rajendra & Syed Suhaib Ahmed. (2023) Exploring the Potential Challenges for Developing Generic Orphan Drugs for Rare Diseases: A Survey of US and European Markets. Value in Health Regional Issues 35, pages 87-94.
Crossref
Crossref
Wenyu Song, Jessica C. Hsu, Xiaoli Lan & Weibo Cai. (2023) Optical image-guided therapy of pancreatic cancer with an ultra-small bispecific protein. European Journal of Nuclear Medicine and Molecular Imaging 50:6, pages 1560-1563.
Crossref
Crossref
Latifa Zekri, Martina Lutz, Nisha Prakash, Timo Manz, Boris Klimovich, Stefanie Mueller, Sebastian Hoerner, Ilona Hagelstein, Monika Engel, Anna Chashchina, Martin Pfluegler, Jonas S. Heitmann, Gundram Jung & Helmut R. Salih. (2023) An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers. Molecular Therapy 31:4, pages 1033-1045.
Crossref
Crossref
Aifang Li, Qianfang Wang, Yu Huang, Lina Hu, Shuxuan Li, Qianqian Wang, Yangfan Yu, Haizhou Zhang, Doris Ying Ying Tang, Pau Loke Show & Shuying Feng. (2023) Can egg yolk antibodies terminate the CSBV infection in apiculture?. Virus Research 328, pages 199080.
Crossref
Crossref
Ajay Kumar Shukla & Saurav Misra. (2023) Bispecific antibodies and its applications: a novel approach for targeting SARS-Cov-2. Journal of Basic and Clinical Physiology and Pharmacology 34:2, pages 161-168.
Crossref
Crossref
Amita Datta-Mannan, Bruce A. Molitoris, Yiqing Feng, Michelle M. Martinez, Ruben M. Sandoval, Robin M. Brown, Daniel Merkel, Johnny E. Croy & Kenneth W. Dunn. (2023) Intravital Microscopy Reveals Unforeseen Biodistribution Within the Liver and Kidney Mechanistically Connected to the Clearance of a Bifunctional Antibody. Drug Metabolism and Disposition 51:3, pages 403-412.
Crossref
Crossref
Akanksha Behl, Zahoor A. Wani, Nagendra Nath Das, Virinder S. Parmar, Christophe Len, Shashwat Malhotra & Anil K. Chhillar. (2023) Monoclonal antibodies in breast cancer: A critical appraisal. Critical Reviews in Oncology/Hematology 183, pages 103915.
Crossref
Crossref
Yeji Hong, Su-Min Nam & Aree Moon. (2023) Antibody–drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry. Archives of Pharmacal Research 46:3, pages 131-148.
Crossref
Crossref
Omozojie P. Aigbogun, Christopher P. Phenix, Ed S. Krol & Eric W. Price. (2023) The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular Pharmaceutics 20:2, pages 853-874.
Crossref
Crossref
Giulia Lambiase, Kerensa Klottrup-Rees, Clare Lovelady, Salma Ali, Samuel Shepherd, Maurizio Muroni, Vivian Lindo, David C. James & Mark J. Dickman. (2023) An automated, low volume, and high-throughput analytical platform for aggregate quantitation from cell culture media. Journal of Chromatography A 1691, pages 463809.
Crossref
Crossref
Daniele Caracciolo, Antonia Mancuso, Nicoletta Polerà, Caterina Froio, Giuseppe D’Aquino, Caterina Riillo, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2023) The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives. Experimental Hematology & Oncology 12:1.
Crossref
Crossref
Eduardo Gonzalez-Ochoa, Ana C Veneziani & Amit M Oza. (2023) Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer. Clinical Medicine Insights: Oncology 17.
Crossref
Crossref
Masahiro Yasunaga. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
31
.
Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh & Nima Rezaei. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
29
.
Fan Zhao, Jiefu Zhu, Lang Shi & Xiongfei Wu. (2022) OGG1 in the Kidney: Beyond Base Excision Repair. Oxidative Medicine and Cellular Longevity 2022, pages 1-13.
Crossref
Crossref
Gang Wu, Chuanfei Yu, Wenbo Wang, Jialiang Du, Gangling Xu, Zhihao Fu & Lan Wang. (2022) Charge Variants Analysis of a Bispecific Antibody Using a Fully Automated
One-step Capillary Isoelectric Focusing - Mass Spectrometry
Method. Current Pharmaceutical Analysis 18:9, pages 860-870.
Crossref
Crossref
Mubarak Al-Mansour. (2022) Treatment Landscape of Relapsed/Refractory Mantle Cell Lymphoma: An Updated Review. Clinical Lymphoma Myeloma and Leukemia 22:11, pages e1019-e1031.
Crossref
Crossref
Tingting Wang, Jie Chen, Xiaobo Du, Gang Feng, Tangzhi Dai, Xinxi Li & Dong Liu. (2022) How neutron scattering techniques benefit investigating structures and dynamics of monoclonal antibody. Biochimica et Biophysica Acta (BBA) - General Subjects 1866:11, pages 130206.
Crossref
Crossref
Tieyi Lu, Li Fu, Yu Qiu, Jifeng Zhang & Zhan Chen. (2022) Probing Molecular Interactions of Antibody Drugs, Silicone Oil, and Surfactant at Buried Interfaces In Situ. Analytical Chemistry 94:42, pages 14761-14768.
Crossref
Crossref
Marina Patysheva, Anastasia Frolova, Irina Larionova, Sergey Afanas'ev, Anna Tarasova, Nadezhda Cherdyntseva & Julia Kzhyshkowska. (2022) Monocyte programming by cancer therapy. Frontiers in Immunology 13.
Crossref
Crossref
Yuqi Yang, Tianjiao Zhao, Qiaohui Chen, Yumei Li, Zuoxiu Xiao, Yuting Xiang, Boyu Wang, Yige Qiu, Shiqi Tu, Yitian Jiang, Yayun Nan, Qiong Huang & Kelong Ai. (2022) Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC. Advanced Science 9:28.
Crossref
Crossref
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, Reshma Murali, D. S. Prabakaran, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Gnanasambandan Ramanathan, George Priya Doss C. & Abilash Valsala Gopalakrishnan. (2022) Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach. Vaccines 10:9, pages 1493.
Crossref
Crossref
Mohsen Karami Fath, Jalil Azami, Alireza Masoudi, Reza Mosaddeghi Heris, Elnaz Rahmani, Fatemeh Alavi, Armina Alagheband Bahrami, Zahra Payandeh, Bahman Khalesi, Masoomeh Dadkhah, Navid Pourzardosht & Vahideh Tarhriz. (2022) Exosome-based strategies for diagnosis and therapy of glioma cancer. Cancer Cell International 22:1.
Crossref
Crossref
Seyed Aria Nejadghaderi, Maryam Balibegloo, Amene Saghazadeh & Nima Rezaei. (2022) Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review. PLOS ONE 17:7, pages e0271506.
Crossref
Crossref
Tomoki Yoneyama, Mi-Sook Kim, Konstantin Piatkov, Haiqing Wang & Andy Z. X. Zhu. (2022) Leveraging a physiologically-based quantitative translational modeling platform for designing B cell maturation antigen-targeting bispecific T cell engagers for treatment of multiple myeloma. PLOS Computational Biology 18:7, pages e1009715.
Crossref
Crossref
Leonie M. Behrens, Timo K. van den Berg & Marjolein van Egmond. (2022) Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils. Cancers 14:14, pages 3366.
Crossref
Crossref
Ashley F. Stein-Merlob, Sarju Ganatra & Eric H. Yang. (2022) T-cell Immunotherapy and Cardiovascular Disease. Heart Failure Clinics 18:3, pages 443-454.
Crossref
Crossref
Caterina Riillo, Daniele Caracciolo, Katia Grillone, Nicoletta Polerà, Franca Maria Tuccillo, Patrizia Bonelli, Giada Juli, Serena Ascrizzi, Francesca Scionti, Mariamena Arbitrio, Mariangela Lopreiato, Maria Anna Siciliano, Simona Sestito, Gabriella Talarico, Eulalia Galea, Maria Concetta Galati, Licia Pensabene, Giovanni Loprete, Marco Rossi, Andrea Ballerini, Massimo Gentile, Domenico Britti, Maria Teresa Di Martino, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2022) A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells. Cancers 14:12, pages 2886.
Crossref
Crossref
Jing Jin, Runyang WangJunhan YangHan HuDi WangLinkang CaiZhizheng FangShuang DongSheng HuYang WangBinlei Liu. (2022) Bispecific Antibody Expressed by an Oncolytic Herpes Simplex Virus Type 2 Can Transform Heterologous T Cells Into Uniform Tumor Killer Cells. Human Gene Therapy 33:11-12, pages 649-663.
Crossref
Crossref
Tingting Xu, Jihong Zhang, Tianyun Wang & Xiaoyin Wang. (2022) Recombinant antibodies aggregation and overcoming strategies in CHO cells. Applied Microbiology and Biotechnology 106:11, pages 3913-3922.
Crossref
Crossref
Fabiana Zappala, Elizabeth Higbee-Dempsey, Bian Jang, Joann MillerLesan Yan, Nicholas G. Minutolo, Gabriela T. Rosado GonzálezAndrew Tsourkas & Burcin Altun Ozdemir. (2022) Rapid, site-specific labeling of “off-the-shelf” and native serum autoantibodies with T cell–redirecting domains. Science Advances 8:18.
Crossref
Crossref
Nikolaos P. Daskalakis, Onno C. Meijer & E. Ron de Kloet. (2022) Mineralocorticoid receptor and glucocorticoid receptor work alone and together in cell-type-specific manner: Implications for resilience prediction and targeted therapy. Neurobiology of Stress 18, pages 100455.
Crossref
Crossref
Suha Abu Khalaf, Dima Dandachi, Bruno P Granwehr & Maria C Rodriguez-Barradas. (2023) Cancer Immunotherapy in Adult Patients with HIV. Journal of Investigative Medicine 70:4, pages 883-891.
Crossref
Crossref
Yoshika Iwata, Yuta Narushima, Asako Harada & Masayuki Mishima. (2022) Priming treatment with T-cell redirecting bispecific antibody ERY974 reduced cytokine induction without losing cytotoxic activity in vitro by changing the chromatin state in T cells. Toxicology and Applied Pharmacology 441, pages 115986.
Crossref
Crossref
Chang-ling Gu, Hai-xia Zhu, Lan Deng, Xiao-qing Meng, Kai Li, Wei Xu, Le Zhao, Yue-qin Liu, Zhen-ping Zhu & Hao-min Huang. (2021) Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition. Acta Pharmacologica Sinica 43:3, pages 672-680.
Crossref
Crossref
Brian J. Thomas, David Porciani & Donald H. Burke. (2022) Cancer immunomodulation using bispecific aptamers. Molecular Therapy - Nucleic Acids 27, pages 894-915.
Crossref
Crossref
Rita Tavarozzi & Enrica Manzato. (2022) The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use. Antibodies 11:1, pages 16.
Crossref
Crossref
Anna Timofeeva, Sergey Sedykh, Lada Maksimenko, Tatyana Sedykh, Sergey Skudarnov, Tatyana Ostapova, Svetlana Yaschenko, Natalya Gashnikova & Georgy Nevinsky. (2022) The Blood of the HIV-Infected Patients Contains κ-IgG, λ-IgG, and Bispecific κλ-IgG, Which Possess DNase and Amylolytic Activity. Life 12:2, pages 304.
Crossref
Crossref
Monica L. Fernández-Quintero, Patrick K. Quoika, Florian S. Wedl, Clarissa A. Seidler, Katharina B. Kroell, Johannes R. Loeffler, Nancy D. Pomarici, Valentin J. Hoerschinger, Alexander Bujotzek, Guy Georges, Hubert Kettenberger & Klaus R. Liedl. (2022) Comparing Antibody Interfaces to Inform Rational Design of New Antibody Formats. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Disha Lu, Xu Wang, Ruijue Su, Yongjian Cheng, Hong Wang, Lin Luo & Zhili Xiao. (2022) Preparation of an Immunoaffinity Column Based on Bispecific Monoclonal Antibody for Aflatoxin B1 and Ochratoxin A Detection Combined with ic-ELISA. Foods 11:3, pages 335.
Crossref
Crossref
Wei Li, Yayu Zhang, Ranjith Kumar Kankala, Liang Zou & Zhoujiang Chen. (2022) Antibody and Cellular-Based Therapies for Pediatric Acute Lymphoblastic Leukemia: Mechanisms and Prospects. Pharmacology 107:7-8, pages 368-375.
Crossref
Crossref
Sami El Khatib & Mohamed Salla. (2022) The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics. Leukemia Research Reports 18, pages 100335.
Crossref
Crossref
Mohammadreza Nassiri, Reihane Behnam-Rasouli, Masoume Vakili-Azghandi, Vinod Gopalan, Peyman Dolati & Rouhollah Nourmohammadi. (2022) Refined immunoRNases for the efficient targeting and selective killing of tumour cells: A novel strategy. Life Sciences 289, pages 120222.
Crossref
Crossref
Aatman S. Doshi & Kirtika H. Asrani. 2022. Cancer Immunology and Immunotherapy. Cancer Immunology and Immunotherapy
19
61
.
Robert S. Foti. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
716
742
.
Mona Sadeghalvad & Nima Rezaei. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
481
493
.
Christian Augsberger, Gerulf Hänel, Wei XuVesna PulkoLydia Jasmin HanischAngelique AugustinJohn ChallierKatharina HuntBinje VickPier Eduardo RovattiChristina KrupkaMaurine RotheAnne SchönleJohannes SamEmmanuelle LezanAxel Ducret, Daniela Ortiz-Franyuti, Antje-Christine Walz, Jörg BenzAlexander Bujotzek, Felix S. LichteneggerChristian GassnerAlejandro CarpyVictor LyamichevJigar PatelNikola KonstandinAntje TungerMarc SchmitzMichael von Bergwelt-BaildonKarsten Spiekermann, Luca Vago, Irmela Jeremias, Estelle Marrer-BergerPablo UmañaChristian Klein & Marion Subklewe. (2021) Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody. Blood 138:25, pages 2655-2669.
Crossref
Crossref
Huinan Qu, Qiu Jin & Chengshi Quan. (2021) CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers. International Journal of Molecular Sciences 22:24, pages 13416.
Crossref
Crossref
Yue Du & Jian Xu. (2021) Engineered Bifunctional Proteins for Targeted Cancer Therapy: Prospects and Challenges. Advanced Materials 33:48.
Crossref
Crossref
Ganggang Bai, Yanhong Ge, Yuhong Su, Shuo Chen, Xingcheng Zeng, Huixia Lu & Buyong Ma. (2021) Computational Construction of a Single-Chain Bi-Paratopic Antibody Allosterically Inhibiting TCR-Staphylococcal Enterotoxin B Binding. Frontiers in Immunology 12.
Crossref
Crossref
Madelyn Espinosa-Cotton & Nai-Kong V. Cheung. (2021) Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor. Frontiers in Oncology 11.
Crossref
Crossref
Qing Zhang, Ling Fang, Boyu Jia, Nan Long, Linchun Shi, Lidong Zhou, Haiping Zhao & Weijun Kong. (2021) Optical lateral flow test strip biosensors for pesticides: Recent advances and future trends. TrAC Trends in Analytical Chemistry 144, pages 116427.
Crossref
Crossref
Ahmed A. Abokor, Grant H. McDaniel, Rachel M. Golonka, Connor Campbell, Sreya Brahmandam, Beng San Yeoh, Bina Joe, Matam Vijay-Kumar & Piu Saha. (2021) Immunoglobulin A, an Active Liaison for Host-Microbiota Homeostasis. Microorganisms 9:10, pages 2117.
Crossref
Crossref
Caizhi Zhao, Wei Zhang, Guihua Gong, Liping Xie, Ming-Wei Wang & Youjia Hu. (2021) A new approach to produce IgG4-like bispecific antibodies. Scientific Reports 11:1.
Crossref
Crossref
Annalee W. Nguyen & Jennifer A. Maynard. 2021. Protein Engineering. Protein Engineering
317
351
.
Ah-Young Song, Hyori Kim, Jung Min Kim, Sang-Hyun Hwang, Dae-Hyun Ko & Hun Sik Kim. (2021) Bispecific Antibody Designed for Targeted NK Cell Activation and Functional Assessment for Biomedical Applications. ACS Applied Materials & Interfaces 13:36, pages 42370-42381.
Crossref
Crossref
Debleena Basu, Sourabrata Chakraborty, Riddhi Pal, Tarun Kumar Sharma & Siddik Sarkar. (2021) Identification and Engineering of Aptamers for Theranostic Application in Human Health and Disorders. International Journal of Molecular Sciences 22:18, pages 9661.
Crossref
Crossref
Charles Shin, Sung Soo Kim & Yong Hwa Jo. (2021) Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications. Molecular Therapy - Oncolytics 22, pages 166-179.
Crossref
Crossref
Hannah E. Dobson, Shasha Ruan, Alfred E. Chang, Max S. Wicha & Qiao Li. (2021)
Targeting cancer stem cells
via
integrin β4
. Oncotarget 12:18, pages 1850-1858.
Crossref
Crossref
Jeffrey A. Dewey, Saara-Anne Azizi, Vivian Lu & Bryan C. Dickinson. (2021) A System for the Evolution of Protein–Protein Interaction Inducers. ACS Synthetic Biology 10:8, pages 2096-2110.
Crossref
Crossref
Petar Rasic, Maja Jovanovic-Tucovic, Marija Jeremic, Slavisa M Djuricic, Zorica V Vasiljevic, Maja Milickovic & Djordje Savic. (2021) B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World Journal of Gastrointestinal Oncology 13:8, pages 799-821.
Crossref
Crossref
Kai-Ge Chen, An Liu, Cheng-Tao Jiang, Dong-Kun Zhao, Qian-Ni Ye, Yu-Qi Liao, Cong-Fei Xu, Song Shen & Jun Wang. (2021) Dual-functional super bispecific nano-antibodies derived from monoclonal antibodies potentiate the antitumor effect of innate immune cells. Nano Today 39, pages 101209.
Crossref
Crossref
Tingwei Ren, Zhijun Tan, Vivekh Ehamparanathan, Angela Lewandowski, Sanchayita Ghose & Zheng Jian Li. (2021) Antibody disulfide bond reduction and recovery during biopharmaceutical process development—A review. Biotechnology and Bioengineering 118:8, pages 2829-2844.
Crossref
Crossref
Andrew T. Lucas, Amber Moody, Allison N. Schorzman & William C. Zamboni. (2021) Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective. Antibodies 10:3, pages 30.
Crossref
Crossref
Shao-Li Huang, Yu-Ming Wang, Quan-Yue Wang, Guang-Gui Feng, Fu-Qing Wu, Liu-Ming Yang, Xi-He Zhang & Hong-Wu Xin. (2021) Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy. Frontiers in Genetics 12.
Crossref
Crossref
Gihoon You, Jonghwa Won, Yangsoon Lee, Dain Moon, Yunji Park, Sang Hoon Lee & Seung-Woo Lee. (2021) Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies. Vaccines 9:7, pages 724.
Crossref
Crossref
Ali Azadi, Alireza Golchini, Sina Delazar, Fatemeh Abarghooi Kahaki, Seyed Mohsen Dehnavi, Zahra Payandeh & Shirin Eyvazi. (2021) Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines. Biological Procedures Online 23:1.
Crossref
Crossref
Meshaal Khan, Ajay V. Maker & Shikha Jain. (2021) The Evolution of Cancer Immunotherapy. Vaccines 9:6, pages 614.
Crossref
Crossref
Kinan Alhallak, Jennifer Sun, Amanda Jeske, Chaelee Park, Jessica Yavner, Hannah Bash, Berit Lubben, Ola Adebayo, Ayah Khaskiah & Abdel Kareem Azab. (2021) Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges. Cancers 13:12, pages 2853.
Crossref
Crossref
Kevin Dang, Giulia Castello, Starlynn C Clarke, Yuping Li, Aarti Balasubramani, Andrew Boudreau, Laura Davison, Katherine E Harris, Duy Pham, Preethi Sankaran, Harshad S Ugamraj, Rong Deng, Serena Kwek, Alec Starzinski, Suhasini Iyer, Wim van Schooten, Ute Schellenberger, Wenchao Sun, Nathan D Trinklein, Roland Buelow, Ben Buelow, Lawrence Fong & Pranjali Dalvi. (2021) Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release. Journal for ImmunoTherapy of Cancer 9:6, pages e002488.
Crossref
Crossref
Csenge Filep, Marton Szigeti, Robert Farsang, Markus Haberger, Dietmar Reusch & Andras Guttman. (2021) Multilevel capillary gel electrophoresis characterization of new antibody modalities. Analytica Chimica Acta 1166, pages 338492.
Crossref
Crossref
Marina Frayberg, Anthony Yung, Leyre Zubiri, Daniel A Zlotoff & Kerry L Reynolds. (2021) What the Cardiologist Needs to Know About Cancer Immunotherapies and Complications. Current Treatment Options in Oncology 22:6.
Crossref
Crossref
Alan H. BaikOlalekan O. OluwoleDouglas B. JohnsonNina ShahJoe-Elie Salem, Katy K. TsaiJavid J. Moslehi. (2021) Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies. Circulation Research 128:11, pages 1780-1801.
Crossref
Crossref
Jiabing Ma, Yicheng Mo, Menglin Tang, Junjie Shen, Yanan Qi, Wenxu Zhao, Yi Huang, Yanmin Xu & Cheng Qian. (2021) Bispecific Antibodies: From Research to Clinical Application. Frontiers in Immunology 12.
Crossref
Crossref
Danesh Hassani, Mohammad Mehdi Amiri, Mehdi Mohammadi, Parisa Yousefi, Mohammad Ali Judaki, Maryam Mobini, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani & Fazel Shokri. (2021) A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2. Current Research in Translational Medicine 69:2, pages 103277.
Crossref
Crossref
Yiyuan Gao, Yuedi Wang, Feifei Luo & Yiwei Chu. (2021) Optimization of T Cell Redirecting Strategies: Obtaining Inspirations From Natural Process of T Cell Activation. Frontiers in Immunology 12.
Crossref
Crossref
Guus A.M.S. van Dongen, Wissam Beaino, Albert D. Windhorst, Gerben J.C. Zwezerijnen, Daniela E. Oprea-Lager, N. Harry Hendrikse, Cornelis van Kuijk, Ronald Boellaard, Marc C. Huisman & Danielle J. Vugts. (2021)
The Role of
89
Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals
. Journal of Nuclear Medicine 62:4, pages 438-445.
Crossref
Crossref
Lijuan Kang, Shengsheng Xu, Yongle Pang, Tom Kirchner, Yue-mei Zhang, Wilson Edwards, Raul Camacho, Lisa Norquay, Naidong Weng & Wenying Jian. (2021) Application of middle-down approach in quantitation and catabolite identification of protein by LC–high-resolution mass spectrometry. Bioanalysis 13:6, pages 465-479.
Crossref
Crossref
Xin Shou, Yuxiao Liu, Dan Wu, Hui Zhang, Yuanjin Zhao, Weijian Sun & Xian Shen. (2021) Black phosphorus quantum dots doped multifunctional hydrogel particles for cancer immunotherapy. Chemical Engineering Journal 408, pages 127349.
Crossref
Crossref
Biagio Ricciuti, Giuseppe Lamberti, Elisa Andrini, Carlo Genova, Andrea De Giglio, Vanessa Bianconi, Amirhossein Sahebkar, Rita Chiari & Matteo Pirro. (2021) Antibody–drug conjugates for lung cancer in the era of personalized oncology. Seminars in Cancer Biology 69, pages 268-278.
Crossref
Crossref
Yingnan Si, Arin L. Melkonian, Keegan C. Curry, Yuanxin Xu, Maranda Tidwell, Mingming Liu, Ahmed F. Zaky & Xiaoguang (Margaret) Liu. (2021) Monoclonal antibody-based cancer therapies. Chinese Journal of Chemical Engineering 30, pages 301-307.
Crossref
Crossref
Mingjian Ding, Li Shen, Liang Xiao, Xiaohui Liu & Jianzhong Hu. (2021) A cell line development strategy to improve a bispecific antibody expression purity in CHO cells. Biochemical Engineering Journal 166, pages 107857.
Crossref
Crossref
Hao Li & George C. Tsokos. (2020) IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases. Clinical Reviews in Allergy & Immunology 60:1, pages 31-45.
Crossref
Crossref
Si-Qi Liu, Alyssa Grantham, Casey Landry, Brian Granda, Rajiv Chopra, Srinivas Chakravarthy, Sabine Deutsch, Markus Vogel, Katie Russo, Katherine Seiss, William R. Tschantz, Tomas Rejtar, David A. Ruddy, Tiancen Hu, Kimberly Aardalen, Joel P. Wagner, Glenn Dranoff & Joseph A. D'Alessio. (2021) A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy. Cancer Immunology Research 9:1, pages 34-49.
Crossref
Crossref
Samvedna Saini & Yatender Kumar. 2021. Translational Biotechnology. Translational Biotechnology
233
266
.
Melvyn LittleMelvyn Little. 2021. Antibodies for Treating Cancer. Antibodies for Treating Cancer
109
125
.
Iago Dillion Lima Cavalcanti & José Cleberson Santos SoaresIago Dillion Lima Cavalcanti & José Cleberson Santos Soares. 2021. Advances in Cancer Treatment. Advances in Cancer Treatment
57
78
.
Chanchal Kumar, Rajat Pratap Singh, Mrigendra Kumar Dwiwedi & Ajay Amit. 2021. Colon Cancer Diagnosis and Therapy. Colon Cancer Diagnosis and Therapy
271
308
.
Jinjiang Li & Duohai Pan. 2021. Protein Instability at Interfaces During Drug Product Development. Protein Instability at Interfaces During Drug Product Development
313
329
.
Laura Rhiel & Stefan Becker. 2021. Introduction to Antibody Engineering. Introduction to Antibody Engineering
129
159
.
Natalie M. Edner, Gianluca Carlesso, James S. Rush & Lucy S. K. Walker. (2020) Targeting co-stimulatory molecules in autoimmune disease. Nature Reviews Drug Discovery 19:12, pages 860-883.
Crossref
Crossref
Hsiang-Ching Wang, Hui-Chen Hung, Peng-Nien Huang, Yu-An Kung, Sung-Nien Tseng, Yun-Ming Wang, Shin-Ru Shih & John Tsu-An Hsu. (2020) Engineering a novel IgG-like bispecific antibody against enterovirus A71. Biochemistry and Biophysics Reports 24, pages 100860.
Crossref
Crossref
Zi-Wen Han, Zhi-Wu Lyv, Bin Cui, Ying-Ying Wang, Jun-Ting Cheng, Ying Zhang, Wen-Qi Cai, Yang Zhou, Zhao-Wu Ma, Xian-Wang Wang, Xiao-Chun Peng, Shu-Zhong Cui, Ying Xiang, Mo Yang & Hong-Wu Xin. (2020) The old CEACAMs find their new role in tumor immunotherapy. Investigational New Drugs 38:6, pages 1888-1898.
Crossref
Crossref
Robert Pytlik, Kamila Polgarova, Jana Karolova & Pavel Klener. (2020) Current Immunotherapy Approaches in Non-Hodgkin Lymphomas. Vaccines 8:4, pages 708.
Crossref
Crossref
Devin Patel, Rana McKay & J. Kellogg Parsons. (2020) Immunotherapy for Localized Prostate Cancer. Urologic Clinics of North America 47:4, pages 443-456.
Crossref
Crossref
Merve Arslan, Dilara Karadag & Sibel Kalyoncu. (2020) Conformational changes in a Vernier zone region: Implications for antibody dual specificity. Proteins: Structure, Function, and Bioinformatics 88:11, pages 1447-1457.
Crossref
Crossref
Alberto Mussetti, Maria Queralt Salas & Vittorio Montefusco. (2020) Allogeneic Hematopoietic Transplantation for Multiple Myeloma in the New Drugs Era: A Platform to Cure. Journal of Clinical Medicine 9:11, pages 3437.
Crossref
Crossref
Ze Tao, Yuehua Liu, Hao Yang, Yanru Feng, Heng Li, Qiuxiao Shi, Shengfu Li, Jingqiu Cheng & Xiaofeng Lu. (2020) Customizing a Tridomain TRAIL Variant to Achieve Active Tumor Homing and Endogenous Albumin-Controlled Release of the Molecular Machine In Vivo. Biomacromolecules 21:10, pages 4017-4029.
Crossref
Crossref
Christoph Gstöttner, Simone Nicolardi, Markus Haberger, Dietmar Reusch, Manfred Wuhrer & Elena Domínguez-Vega. (2020) Intact and subunit-specific analysis of bispecific antibodies by sheathless CE-MS. Analytica Chimica Acta 1134, pages 18-27.
Crossref
Crossref
Tim Hofmann, Simon Krah, Carolin Sellmann, Stefan Zielonka & Achim Doerner. (2020) Greatest Hits—Innovative Technologies for High Throughput Identification of Bispecific Antibodies. International Journal of Molecular Sciences 21:18, pages 6551.
Crossref
Crossref
Prudence PokWai Lui, Inchul Cho & Niwa Ali. (2020) Tissue regulatory T cells. Immunology 161:1, pages 4-17.
Crossref
Crossref
Chenjiang Liu, Yoshihiro Kobashigawa, Soichiro Yamauchi, Natsuki Fukuda, Takashi Sato, Takeshi Masuda, Sumio Ohtsuki & Hiroshi Morioka. (2020) Convenient method of producing cyclic single-chain Fv antibodies by split-intein-mediated protein ligation and chaperone co-expression. The Journal of Biochemistry 168:3, pages 257-263.
Crossref
Crossref
Annamaria Sandomenico, Jwala P. Sivaccumar & Menotti Ruvo. (2020) Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments. International Journal of Molecular Sciences 21:17, pages 6324.
Crossref
Crossref
Masahiro Yasunaga. (2020) Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Seminars in Cancer Biology 64, pages 1-12.
Crossref
Crossref
Sung In Lim. (2020) Fine-tuning bispecific therapeutics. Pharmacology & Therapeutics 212, pages 107582.
Crossref
Crossref
Evgeny A. Ermakov, Georgy A. Nevinsky & Valentina N. Buneva. (2020) Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States. International Journal of Molecular Sciences 21:15, pages 5392.
Crossref
Crossref
Haitao Jiang, Wei Xu, Ren Liu, Balrina Gupta, Bruce Kilgore, Zhimei Du & Xiaoyu Yang. (2020) Characterization of Bispecific Antibody Production in Cell Cultures by Unique Mixed Mode Size Exclusion Chromatography. Analytical Chemistry 92:13, pages 9312-9321.
Crossref
Crossref
Nina Shah, Jack Aiello, David E Avigan, Jesus G Berdeja, Ivan M Borrello, Ajai Chari, Adam D Cohen, Karthik Ganapathi, Lissa Gray, Damian Green, Amrita Krishnan, Yi Lin, Elisabet Manasanch, Nikhil C Munshi, Ajay K Nooka, Aaron P Rapoport, Eric L Smith, Ravi Vij & Madhav Dhodapkar. (2020) The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma. Journal for ImmunoTherapy of Cancer 8:2, pages e000734.
Crossref
Crossref
Anniina Jaakkonen, Gerrit Volkmann & Hideo Iwaï. (2020) An Off-the-Shelf Approach for the Production of Fc Fusion Proteins by Protein Trans-Splicing towards Generating a Lectibody In Vitro. International Journal of Molecular Sciences 21:11, pages 4011.
Crossref
Crossref
Muhammad Kalim, Muhammad Saleem Iqbal Khan & Jinbiao Zhan. (2020) Programmed cell death ligand‐1: A dynamic immune checkpoint in cancer therapy. Chemical Biology & Drug Design 95:6, pages 552-566.
Crossref
Crossref
Josée Golay & Alain E. Andrea. (2020) Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies. Antibodies 9:2, pages 17.
Crossref
Crossref
Chiara Caraccio, Sachi Krishna, Darci J. Phillips & Christian M. Schürch. (2020) Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions. Frontiers in Immunology 11.
Crossref
Crossref
Veronica Mendoza-Reinoso, Laurie K. McCauley & Pierrick G.J. Fournier. (2020) Contribution of Macrophages and T Cells in Skeletal Metastasis. Cancers 12:4, pages 1014.
Crossref
Crossref
Julien Camperi, Davy Guillarme, Ming Lei & Cinzia Stella. (2020) Automated middle-up approach for the characterization of biotherapeutic products by combining on-line hinge-specific digestion with RPLC-HRMS analysis. Journal of Pharmaceutical and Biomedical Analysis 182, pages 113130.
Crossref
Crossref
Nicole Swope, Wai Keen Chung, Mingyan Cao, Dana Motabar, Dengfeng Liu, Sanjeev Ahuja & Michael Handlogten. (2020) Impact of enzymatic reduction on bivalent bispecific antibody fragmentation and loss of product purity upon reoxidation. Biotechnology and Bioengineering 117:4, pages 1063-1071.
Crossref
Crossref
Antoine Maruani, Peter A. Szijj, Calise Bahou, João C. F. Nogueira, Stephen Caddick, James R. Baker & Vijay Chudasama. (2020)
A Plug-and-Play Approach for the
De Novo
Generation of Dually Functionalized Bispecifics
. Bioconjugate Chemistry 31:3, pages 520-529.
Crossref
Crossref
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson, Katherine I. Miller Needleman, James Valentine, Kay Davies, Stephen C. Groft, Robert Preti, Tudor I. Oprea & Marco Prunotto. (2019) Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery 19:2, pages 93-111.
Crossref
Crossref
Manzoor A. Mir, Umar Mehraj, Bashir Ahmad Sheikh & Syed Suhail Hamdani. (2020) Nanobodies: The “Magic Bullets” in therapeutics, drug delivery and diagnostics. Human Antibodies 28:1, pages 29-51.
Crossref
Crossref
Josée Golay & Mario Regazzi. (2020) Key Features Defining the Disposition of Bispecific Antibodies and Their Efficacy In Vivo. Therapeutic Drug Monitoring 42:1, pages 57-63.
Crossref
Crossref
Saki Hemmi, Ryutaro Asano, Kouki Kimura, Mitsuo Umetsu, Takeshi Nakanishi, Izumi Kumagai & Koki Makabe. (2020) Construction of a circularly connected VHH bispecific antibody (cyclobody) for the desirable positioning of antigen-binding sites. Biochemical and Biophysical Research Communications 523:1, pages 72-77.
Crossref
Crossref
Anne Ljungars, Torbjörn Schiött, Ulrika Mattson, Jessica Steppa, Björn Hambe, Monika Semmrich, Mats Ohlin, Ulla-Carin Tornberg & Mikael Mattsson. (2020) A bispecific IgG format containing four independent antigen binding sites. Scientific Reports 10:1.
Crossref
Crossref
Peilu Liu, Xuan Gao, Victor Lundin, Catherine Shi, Yilma Adem, Kevin Lin, Guoying Jiang, Yung-Hsiang Kao, Feng Yang, David Michels, Alan G. Marshall & Hui-Min Zhang. (2019) Probing the Impact of the Knob-into-Hole Mutations on the Structure and Function of a Therapeutic Antibody. Analytical Chemistry 92:1, pages 1582-1588.
Crossref
Crossref
Puregmaa Khongorzul, Cai Jia Ling, Farhan Ullah Khan, Awais Ullah Ihsan & Juan Zhang. (2020) Antibody–Drug Conjugates: A Comprehensive Review. Molecular Cancer Research 18:1, pages 3-19.
Crossref
Crossref
Tim Hofmann, Johannes Schmidt, Elke Ciesielski, Stefan Becker, Thomas Rysiok, Mark Schütte, Lars Toleikis, Harald Kolmar & Achim Doerner. (2020) Intein mediated high throughput screening for bispecific antibodies. mAbs 12:1.
Crossref
Crossref
Steffen Dickopf, Guy J. Georges & Ulrich Brinkmann. (2020) Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies. Computational and Structural Biotechnology Journal 18, pages 1221-1227.
Crossref
Crossref
Sylvia Dietrich, Alec W. Gross, Stefan Becker, Björn Hock, Gerhard Stadlmayr, Florian Rüker & Gordana Wozniak-Knopp. (2020) Constant domain-exchanged Fab enables specific light chain pairing in heterodimeric bispecific SEED-antibodies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1868:1, pages 140250.
Crossref
Crossref
Steven A. Berkowitz. 2020. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
459
479
.
Christoffer B. Lambring, Chloe Smith, Sohail Siraj, Krishna Patel & Riyaz Basha. 2020. Theranostics Approaches to Gastric and Colon Cancer. Theranostics Approaches to Gastric and Colon Cancer
209
230
.
W. Blaine Stine, Dana I. Filoti & Tariq Ghayur. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products
91
115
.
Supriya Gupta, Amr Alaarg, Zhen Wu, Xiaofeng Lu, VivekKumar Garripelli, Hanmin Dong, Stephanie Sawilla, Bhargav Patel & Rudolf Schroeder. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products
431
459
.
Patrícia de Sousa-Pereira & Jenny M. Woof. (2019) IgA: Structure, Function, and Developability. Antibodies 8:4, pages 57.
Crossref
Crossref
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov & Gary L. Gilliland. (2019) Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies 8:4, pages 55.
Crossref
Crossref
Oleksii O. Peltek, Albert R. Muslimov, Mikhail V. Zyuzin & Alexander S. Timin. (2019) Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. Journal of Nanobiotechnology 17:1.
Crossref
Crossref
Wilson Phung, Guanghui Han, Stéphanie G.I. Polderdijk, Michael Dillon, Whitney Shatz, Peter Liu, Bingchuan Wei, Pawankumar Suresh, David Fischer, Christoph Spiess, Aaron Bailey, Paul J. Carter, Jennie R. Lill & Wendy Sandoval. (2019) Characterization of bispecific and mispaired IgGs by native charge-variant mass spectrometry. International Journal of Mass Spectrometry 446, pages 116229.
Crossref
Crossref
María Sofía Castelli, Paul McGonigle & Pamela J. Hornby. (2019) The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacology Research & Perspectives 7:6.
Crossref
Crossref
Matthew T. Witkowski, Audrey Lasry, William L. Carroll & Iannis Aifantis. (2019) Immune-Based Therapies in Acute Leukemia. Trends in Cancer 5:10, pages 604-618.
Crossref
Crossref
Johannes Duell, Philip E. Lammers, Ivana Djuretic, Allison G. Chunyk, Shilpa Alekar, Ira Jacobs & Saar Gill. (2019) Bispecific Antibodies in the Treatment of Hematologic Malignancies. Clinical Pharmacology & Therapeutics 106:4, pages 781-791.
Crossref
Crossref
Raoufeh Ahamadi-Fesharaki, Abolfazl Fateh, Farzam Vaziri, Ghasem Solgi, Seyed Davar Siadat, Fereidoun Mahboudi & Fatemeh Rahimi-Jamnani. (2019) Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow. Molecular Therapy - Oncolytics 14, pages 38-56.
Crossref
Crossref
Lucas K. Kimerer, Timothy M. Pabst, Alan K. Hunter & Giorgio Carta. (2019) Chromatographic behavior of bivalent bispecific antibodies on cation exchange columns. I. Experimental observations and phenomenological model. Journal of Chromatography A 1601, pages 121-132.
Crossref
Crossref
Jan P. Bogen, Steffen C. Hinz, Julius Grzeschik, Aileen Ebenig, Simon Krah, Stefan Zielonka & Harald Kolmar. (2019) Dual Function pH Responsive Bispecific Antibodies for Tumor Targeting and Antigen Depletion in Plasma. Frontiers in Immunology 10.
Crossref
Crossref
Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland & Michael J. Betenbaugh. (2019) Design and Production of Bispecific Antibodies. Antibodies 8:3, pages 43.
Crossref
Crossref
Rajesh Kumar, Hilal Ahmed Parray, Tripti Shrivastava, Subrata Sinha & Kalpana Luthra. (2019) Phage display antibody libraries: A robust approach for generation of recombinant human monoclonal antibodies. International Journal of Biological Macromolecules 135, pages 907-918.
Crossref
Crossref
Hongcheng Yang, Ruoyang Shao, Hongxin Huang, Xinlong Wang, Zhili Rong & Ying Lin. (2019) Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRPɑ axis. Cancer Medicine 8:9, pages 4245-4253.
Crossref
Crossref
Soichiro Yamauchi, Yoshihiro Kobashigawa, Natsuki Fukuda, Manaka Teramoto, Yuya Toyota, Chenjiang Liu, Yuka Ikeguchi, Takashi Sato, Yuko Sato, Hiroshi Kimura, Takeshi Masuda, Sumio Ohtsuki, Kentaro Noi, Teru Ogura & Hiroshi Morioka. (2019) Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions. Molecules 24:14, pages 2620.
Crossref
Crossref
Amita Datta-Mannan, Robin M. Brown, Jonathan Fitchett, Aik Roy Heng, Deepa Balasubramaniam, Jennifer Pereira & Johnny E. Croy. (2019) Modulation of the Biophysical Properties of Bifunctional Antibodies as a Strategy for Mitigating Poor Pharmacokinetics. Biochemistry 58:28, pages 3116-3132.
Crossref
Crossref
Derrick E. Akpalu, Bart Frederick, Ivo P. Nnane, Zhenling Yao, Fang Shen, Tatiana Ort, Damien Fink, Shannon Dogmanits, Donald Raible, Amarnath Sharma & Zhenhua Xu. (2019) Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety, and Tolerability of JNJ‐61178104, a Novel Tumor Necrosis Factor‐Alpha and Interleukin‐17A Bispecific Antibody, in Healthy Subjects. The Journal of Clinical Pharmacology 59:7, pages 968-978.
Crossref
Crossref
Rongjun He, Brian Finan, John P. Mayer & Richard D. DiMarchi. (2019) Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety. Molecules 24:10, pages 1855.
Crossref
Crossref
Steven W. de Taeye, Theo Rispens & Gestur Vidarsson. (2019) The Ligands for Human IgG and Their Effector Functions. Antibodies 8:2, pages 30.
Crossref
Crossref
Anja S. Schmid & Dario Neri. (2019) Advances in antibody engineering for rheumatic diseases. Nature Reviews Rheumatology 15:4, pages 197-207.
Crossref
Crossref
Elisabeth G. E. de Vries, Laura Kist de Ruijter, Marjolijn N. Lub-de Hooge, Rudi A. Dierckx, Sjoerd G. Elias & Sjoukje F. Oosting. (2018) Integrating molecular nuclear imaging in clinical research to improve anticancer therapy. Nature Reviews Clinical Oncology 16:4, pages 241-255.
Crossref
Crossref
J.-Pablo Salvador, Lluïsa Vilaplana & M.-Pilar Marco. (2019) Nanobody: outstanding features for diagnostic and therapeutic applications. Analytical and Bioanalytical Chemistry 411:9, pages 1703-1713.
Crossref
Crossref
Shixue Chen, Lingling Li, Fan Zhang, Yu Wang, Yi Hu & Lei Zhao. (2019) Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy. Journal of Immunology Research 2019, pages 1-13.
Crossref
Crossref
Rossella Talotta, Francesco Rucci, Gianfranco Canti & Francesco Scaglione. (2019) Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: a lesson from autoimmune diseases. Immunotherapy 11:3, pages 241-254.
Crossref
Crossref
Giulia Fabozzi, Amarendra Pegu, Richard A. Koup & Constantinos Petrovas. (2019) Bispecific antibodies: Potential immunotherapies for HIV treatment. Methods 154, pages 118-124.
Crossref
Crossref
Ashley R. Sutherland, Md. Kausar Alam & C. Ronald Geyer. (2018) Post‐translational Assembly of Protein Parts into Complex Devices by Using SpyTag/SpyCatcher Protein Ligase. ChemBioChem 20:3, pages 319-328.
Crossref
Crossref
S. E. Sedykh & G. A. Nevinsky. (2019) Producing and prospects for the use of bispecific antibodies for the treatment of cancer. Advances in molecular oncology 5:4, pages 30-40.
Crossref
Crossref
J. Posner, P. Barrington, T. Brier & A. Datta-Mannan. 2019. Concepts and Principles of Pharmacology. Concepts and Principles of Pharmacology
81
141
.
Krupa Naran, Trishana Nundalall, Shivan Chetty & Stefan Barth. (2018) Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases. Frontiers in Microbiology 9.
Crossref
Crossref
Karie Runcie, Daniel R. Budman, Veena John & Nagashree Seetharamu. (2018) Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics. Molecular Medicine 24:1.
Crossref
Crossref
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera & Brigitte M. Pützer. (2018) Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Seminars in Cancer Biology 53, pages 90-109.
Crossref
Crossref
Sofie Mylle, Lynda Grine, Reinhart Speeckaert, Jo L.W. Lambert & Nanja van Geel. (2018) Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly. American Journal of Clinical Dermatology 19:5, pages 625-637.
Crossref
Crossref
Simon Krah, Harald Kolmar, Stefan Becker & Stefan Zielonka. (2018) Engineering IgG-Like Bispecific Antibodies—An Overview. Antibodies 7:3, pages 28.
Crossref
Crossref
Irina V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Sergey M. Deyev & Roman V. Kholodenko. (2018) Neuroblastoma Origin and Therapeutic Targets for Immunotherapy. Journal of Immunology Research 2018, pages 1-25.
Crossref
Crossref
John W. Hickey, Alyssa K. Kosmides & Jonathan P. Schneck. 2018. Biology of T Cells - Part A. Biology of T Cells - Part A
277
362
.
Jing Jin, Runyang Wang, Junhan Yang, Han Hu, Di Wang, Linkang Cai, Zhizheng Fang, Shuang Dong, Shen Hu, Yang Wang & Binlei Liu. (2021) BiTEs Expressed by an Oncolytic Herpes Simplex Virus Type 2 Can Transform Heterologous T Cells Into Uniform Tumor Killer Cells. SSRN Electronic Journal.
Crossref
Crossref